These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 2426597)
1. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123 [TBL] [Abstract][Full Text] [Related]
3. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
4. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria. Haanen JB; Ottenhoff TH; Lai A Fat RF; Soebono H; Spits H; de Vries RR J Immunol; 1990 Dec; 145(11):3898-904. PubMed ID: 1701000 [TBL] [Abstract][Full Text] [Related]
5. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
6. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369 [TBL] [Abstract][Full Text] [Related]
7. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
8. Human suppressor T cell clones lack CD28. Li SG; Ottenhoff TH; Van den Elsen P; Koning F; Zhang L; Mak T; De Vries RR Eur J Immunol; 1990 Jun; 20(6):1281-8. PubMed ID: 2164478 [TBL] [Abstract][Full Text] [Related]
9. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
10. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors. Mohagheghpour N; Gelber RR; Engleman EG J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952 [TBL] [Abstract][Full Text] [Related]
11. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
12. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells. Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353 [TBL] [Abstract][Full Text] [Related]
13. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
14. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920 [TBL] [Abstract][Full Text] [Related]
15. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Nath I; Van Rood JJ; Mehra NK; Vaidya MC Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335 [TBL] [Abstract][Full Text] [Related]
16. The immunobiology of leprosy. Kaplan G; Cohn ZA Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762 [TBL] [Abstract][Full Text] [Related]
18. T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones. Van Schooten WC; Ottenhoff TH; Klatser PR; Thole J; De Vries RR; Kolk AH Eur J Immunol; 1988 Jun; 18(6):849-54. PubMed ID: 2454825 [TBL] [Abstract][Full Text] [Related]
19. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888 [TBL] [Abstract][Full Text] [Related]
20. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]